Northern Trust’s Altimmune ALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.07M | Buy |
996,721
+280,730
| +39% | +$1.19M | ﹤0.01% | 2733 |
|
|
2025
Q4 | $2.58M | Buy |
715,991
+58,975
| +9% | +$257K | ﹤0.01% | 2847 |
|
|
2025
Q3 | $2.48M | Buy |
657,016
+16,670
| +3% | +$64.4K | ﹤0.01% | 2914 |
|
|
2025
Q2 | $2.48M | Buy |
640,346
+3,640
| +0.6% | +$19.7K | ﹤0.01% | 2864 |
|
|
2025
Q1 | $3.18M | Sell |
636,706
-29,210
| -4% | -$185K | ﹤0.01% | 2665 |
|
|
2024
Q4 | $4.8M | Buy |
665,916
+35,918
| +6% | +$274K | ﹤0.01% | 2528 |
|
|
2024
Q3 | $3.87M | Buy |
629,998
+102,701
| +19% | +$696K | ﹤0.01% | 2628 |
|
|
2024
Q2 | $3.51M | Buy |
527,297
+33,329
| +7% | +$246K | ﹤0.01% | 2590 |
|
|
2024
Q1 | $5.03M | Buy |
493,968
+20,139
| +4% | +$205K | ﹤0.01% | 2447 |
|
|
2023
Q4 | $5.33M | Buy |
473,829
+23,419
| +5% | +$97.8K | ﹤0.01% | 2474 |
|
|
2023
Q3 | $1.17M | Buy |
450,410
+27,974
| +7% | +$80.3K | ﹤0.01% | 3232 |
|
|
2023
Q2 | $1.49M | Buy |
422,436
+280,397
| +197% | +$1.26M | ﹤0.01% | 3185 |
|
|
2023
Q1 | $599K | Buy |
142,039
+2,121
| +2% | +$25.2K | ﹤0.01% | 3392 |
|
|
2022
Q4 | $2.3M | Buy |
139,918
+28,529
| +26% | +$320K | ﹤0.01% | 2926 |
|
|
2022
Q3 | $1.42M | Buy |
111,389
+9,600
| +9% | +$142K | ﹤0.01% | 3175 |
|
|
2022
Q2 | $1.19M | Sell |
101,789
-258,338
| -72% | -$1.59M | ﹤0.01% | 3297 |
|
|
2022
Q1 | $2.19M | Sell |
360,127
-16,357
| -4% | -$120K | ﹤0.01% | 3053 |
|
|
2021
Q4 | $3.45M | Sell |
376,484
-10,806
| -3% | -$115K | ﹤0.01% | 2927 |
|
|
2021
Q3 | $4.38M | Buy |
387,290
+55,000
| +17% | +$669K | ﹤0.01% | 2812 |
|
|
2021
Q2 | $3.27M | Buy |
332,290
+241,637
| +267% | +$3.3M | ﹤0.01% | 3100 |
|
|
2021
Q1 | $1.28M | Sell |
90,653
-14,143
| -13% | -$229K | ﹤0.01% | 3481 |
|
|
2020
Q4 | $1.18M | Sell |
104,796
-9,850
| -9% | -$116K | ﹤0.01% | 3452 |
|
|
2020
Q3 | $1.51M | Buy |
114,646
+16,857
| +17% | +$337K | ﹤0.01% | 3195 |
|
|
2020
Q2 | $1.05M | Buy |
97,789
+84,796
| +653% | +$466K | ﹤0.01% | 3336 |
|
|
2020
Q1 | $42K | Hold |
12,993
| – | – | ﹤0.01% | 3976 |
|
|
2019
Q4 | $25K | Sell |
12,993
-2,863
| -18% | -$5.29K | ﹤0.01% | 4138 |
|
|
2019
Q3 | $31K | Buy |
+15,856
| New | +$35.1K | ﹤0.01% | 4114 |
|
|
2018
Q3 | – | Sell |
-564
| Closed | -$8K | – | 4308 |
|
|
2018
Q2 | $8K | Hold |
564
| – | – | ﹤0.01% | 4259 |
|
|
2018
Q1 | $20K | Buy |
564
+185
| +49% | +$9.28K | ﹤0.01% | 4167 |
|
|
2017
Q4 | $23K | Hold |
379
| – | – | ﹤0.01% | 4147 |
|
|
2017
Q3 | $26K | Hold |
379
| – | – | ﹤0.01% | 4129 |
|
|
2017
Q2 | $36K | Sell |
379
-1,835
| -83% | -$305K | ﹤0.01% | 4119 |
|
|
2017
Q1 | $539K | Buy |
2,214
+16
| +0.7% | +$8.56K | ﹤0.01% | 3510 |
|
|
2016
Q4 | $2.14M | Buy |
2,198
+15
| +0.7% | +$13.4K | ﹤0.01% | 3049 |
|
|
2016
Q3 | $1.9M | Buy |
2,183
+87
| +4% | +$68.2K | ﹤0.01% | 3095 |
|
|
2016
Q2 | $1.53M | Buy |
2,096
+1,887
| +903% | +$1.29M | ﹤0.01% | 3169 |
|
|
2016
Q1 | $119K | Sell |
209
-19
| -8% | -$9.72K | ﹤0.01% | 3865 |
|
|
2015
Q4 | $130K | Hold |
228
| – | – | ﹤0.01% | 3875 |
|
|
2015
Q3 | $91K | Buy |
228
+15
| +7% | +$7.11K | ﹤0.01% | 3951 |
|
|
2015
Q2 | $115K | Sell |
213
-42
| -16% | -$21.2K | ﹤0.01% | 3926 |
|
|
2015
Q1 | $125K | Hold |
255
| – | – | ﹤0.01% | 3994 |
|
|
2014
Q4 | $139K | Hold |
255
| – | – | ﹤0.01% | 3902 |
|
|
2014
Q3 | $136K | Sell |
255
-12
| -4% | -$6.28K | ﹤0.01% | 3950 |
|
|
2014
Q2 | $113K | Buy |
267
+2
| +0.8% | +$904 | ﹤0.01% | 3983 |
|
|
2014
Q1 | $146K | Hold |
265
| – | – | ﹤0.01% | 3859 |
|
|
2013
Q4 | $148K | Sell |
265
-8
| -3% | -$4.77K | ﹤0.01% | 3790 |
|
|
2013
Q3 | $172K | Buy |
273
+6
| +2% | +$3.44K | ﹤0.01% | 3695 |
|
|
2013
Q2 | $128K | Buy |
+267
| New | +$132K | ﹤0.01% | 3759 |
|
Other funds holding ALT
VCM
VPM
N
Northern Trust's ALT Position: Q1 2026 in Review
Northern Trust increased its Altimmune (ALT) stake by 39% in Q1 2026, buying an estimated $1.19M and bringing the position to 996,721 shares worth $3.07M. The position accounts for ﹤0.01% of the portfolio, ranked #2733.
Northern Trust first reported a position in ALT in Q2 2013 and has held it in 48 quarters since. The position peaked at $5.33M in Q4 2023. 173 funds tracked by Wall St. Rank hold ALT as of Q1 2026.
- Northern Trust held 996,721 shares of Altimmune worth $3.07M as of Q1 2026.
- Northern Trust bought 280,730 Altimmune shares in Q1 2026, an estimated $1.19M.
- Altimmune made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #2733 holding.
- Northern Trust first reported a position in Altimmune in Q2 2013 and has held it in 48 quarters since.
- Northern Trust's Altimmune position peaked at $5.33M in Q4 2023.
- 173 funds tracked by Wall St. Rank held Altimmune as of Q1 2026.
Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.